Preoperative and postoperative dextromethorphan provides sustained reduction in postoperative pain and patient‐controlled epidural analgesia requirement

Abstract

A 3-day DM administration is associated with better pain reduction in patients undergoing surgery for bone malignancy under combined general and epidural anesthesia with postoperative PCEA compared with placebo without increasing side effects.